|
| 33849683 | Auditory discrimination and frequency modulation learning in schizophrenia patients: amphetamine within-subject dose response and time course. | Psychol Med | 2023 |
| 37074079 | Comparison of Delivery of Care Before and During COVID-19 Within an Academic Outpatient Psychiatry Practice. | Telemed J E Health | 2023 |
| 35042948 | EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participants. | Neuropsychopharmacology | 2022 |
| 35864090 | Correction to: Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms. | Transl Psychiatry | 2022 |
| 35132440 | Amphetamine alters an EEG marker of reward processing in humans and mice. | Psychopharmacology (Berl) | 2022 |
| 34535625 | Electrophysiological biomarkers of behavioral dimensions from cross-species paradigms. | Transl Psychiatry | 2021 |
| 32340927 | Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia. | Biol Psychiatry Cogn Neurosci Neuroimaging | 2020 |
| 32961542 | Memantine effects on auditory discrimination and training in schizophrenia patients. | Neuropsychopharmacology | 2020 |
| 29601286 | Implementing a college mental health program - an overview of the first twelve months. | J Am Coll Health | 2019 |
| 31187152 | Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans. | Psychopharmacology (Berl) | 2019 |
| 31445502 | Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patients. | Neuropsychopharmacology | 2019 |
| 28711472 | Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia. | Schizophr Res | 2018 |
| 29627173 | Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge. | Schizophr Res | 2018 |
| 29154367 | Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients. | Neuropsychopharmacology | 2018 |
| 27798224 | Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients. | Schizophr Bull | 2017 |
| 28425497 | Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia. | Neuropsychopharmacology | 2017 |
| 29020372 | Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors. | Int J Neuropsychopharmacol | 2017 |
| 28754432 | The 5 choice continuous performance test (5C-CPT): A novel tool to assess cognitive control across species. | J Neurosci Methods | 2017 |
| 28027936 | Sensorimotor gating in healthy adults tested over a 15 year period. | Biol Psychol | 2017 |
| 26062785 | Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis. | Neuropsychopharmacology | 2016 |
| 27076209 | Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategy. | Psychopharmacology (Berl) | 2016 |
| 24478731 | Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans. | Front Psychiatry | 2014 |
| 23093223 | Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study. | Neuropsychopharmacology | 2013 |
| 21845389 | The safety of studies with intravenous οâ¹-tetrahydrocannabinol in humans, with case histories. | Psychopharmacology (Berl) | 2012 |
| 22784685 | The COMT Met158 allele and violence in schizophrenia: a meta-analysis. | Schizophr Res | 2012 |
| 22717030 | Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia. | Biol Psychiatry | 2012 |
| 22910407 | The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions. | Schizophr Res | 2012 |
| 20190597 | The safety and efficacy of benzodiazepine-modified treatments as a special form of unmodified ECT. | J ECT | 2010 |
| 21180413 | Familial vulnerability to an unusual cognitive adverse effect of topiramate: Discussion of mechanisms. | Indian J Psychiatry | 2010 |
| 19153888 | Melatonin treatment of shoulder-and-neck dyskinesia possibly related to fluoxetine treatment. | World J Biol Psychiatry | 2009 |
| 19823633 | Systematic enhancement of functioning as a therapeutic technique in conversion disorder. | Indian J Psychiatry | 2009 |
| 18228005 | Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans. | Psychopharmacology (Berl) | 2008 |
| 17335321 | Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study. | J Clin Psychiatry | 2007 |
| 18090690 | Schizophrenia, osteoporosis, and an examination of the risk of fractures in patients receiving ECT. | J ECT | 2007 |
| 16669735 | Simultaneous true seizures and pseudoseizures. | J Clin Psychiatry | 2006 |
| 17071546 | Controversy revisited: Selective serotonin reuptake inhibitors in paediatric depression. | World J Biol Psychiatry | 2006 |